Where is Ways2Well located?

Ways2Well is headquartered in Texas City, United States.

How many employees does Ways2Well have?

As of Jul 31, 2026, the latest employee count at Ways2Well is 127.

Where does Ways2Well rank among its competitors?

Ways2Well ranks 24th amongst 97 active competitors, of which 8 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Molecular Instruments, which secured $906K in Sep, 2024.

Who are the top competitors of Ways2Well?

Ways2Well's top competitors include InformedDNA, Genewiz and Dante Omics. Among them, Molecular Instruments secured the most recent funding round in September, 2024.

Ways2Well - 2026 Company Profile & Competitors

Company Details

Website: ways2well.com
Social
Email ID: *****@ways2well.com
Phone Number: +1 **********

Key Metrics

Founded Year

2018

Location

Texas City, United States

Stage

Unfunded

Ranked

24^th among 97 active competitors

Employee Count

127 as on Jul 31, 2026

Similar Companies

BGI & 361 more

View Ways2Well's full profile

Ways2Well has not raised any funding rounds yet.

Ways2Well's employee count trend

Ways2Well has 127 employees as of Jul 26. Here is Ways2Well's employee count trend over the years:

Uncover Ways2Well's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Ways2Well include InformedDNA, Genewiz and Dante Omics. Here is the list of Top 10 competitors of Ways2Well, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	InformedDNA 2007, St Petersburg (United States), Series A	Provider of network of genetics experts to help patients and providers	$19.2M	Frist Cressey Ventures, NovaQuest Capital Management ... & 5 others	57/100
2nd	Genewiz 1999, South Plainfield (United States), Acquired	Provider of a wide range of genomic services for the life sciences industry	-	Orbimed, Ampersand Capital & 6 others	52/100
3rd	Dante Omics 2016, New York City (United States), Unfunded	Provider of genomic services and solutions for researchers, laboratories, and healthcare professionals	-	-	48/100
4th	Transnetyx 2000, Memphis (United States), Acquired	Developer of automated-genotyping services for murine cell lines	-	Abacus Finance Group, ventureCapital.org & 2 others	47/100
5th	Macrogen 1997, Seoul (South Korea), Public	Provider of a platform for next-generation sequencing	-	Atinum Investment, Aju IB Investment & 1 others	46/100
6th	Centrillion Technologies 2009, Palo Alto (United States), Series C	Developer of DNA chips and molecular assays	$103M	WeDoctor, Westlake Ventures & 9 others	45/100
7th	AKESOgen 2010, Norcross (United States), Seed	Provider of research services for scientists doing clinical and basic research	$1.5M	Georgia Research Alliance	43/100
8th	Avance Biosciences 2010, Houston (United States), Unfunded	Company offering sequencing and PCR based services for assay validation and other clinical trial applications	-	-	43/100
9th	Molecular Instruments 2018, Los Angeles (United States), Funding Raised	Provider and developer of molecular instruments for drug development	-	HHS	42/100
10th	Clear Genetics 2016, San Francisco (United States), Acquired	Provider of chatbot and telemedicine platform to interpret genetic results	$120K	Alchemist Accelerator, SIB Investment Group ... & 6 others	41/100
24th	Ways2Well 2018, Texas City (United States), Unfunded	Provider of online platform offering telemedicine services	-	-	30/100